GOOD

Circumventing the Market to Relieve Paralysis

Devices exist to relieve paralysis from spinal cord injury, but there aren’t enough patients to make selling the technology profitable.



You’ve been in a terrible accident. Everyone says that you are lucky to have survived, and you are. But a severe spinal cord injury means you can’t use your hands for the simplest tasks. Your family brushes your teeth and dresses you each day. You’ve lost bowel and bladder control. Sex will never be the same. But there is an alternative: a neuroprosthesis (a prosthetic nervous system) could restore function to your body, part by part.

This remarkable technology exists, but you can’t have it.


“It’s all economics,” explains Julie Jacono, director of Case Western Reserve University’s Institute for Functional Restoration (IFR), a nonprofit corporate surrogate that is pushing forward the final stage of testing for a platform of six neuroprostheses. The various implantable devices can each restore function to different parts of the body—allowing paralyzed patients to do things like stand again or move their hands. It’s incredibly promising. But because so few people suffer from spinal cord injuries, it isn’t profitable for a company to take the technology to market.

Most of us assume that once discoveries are uncovered in the lab, they’ll eventually make their way to patients. “It’s a field of dreams story, that if you build it they will come,” says P. Hunter Peckham, bioengineering professor and executive director of the Institute. “But I think we all know that that’s not the way any of these things work.”

According to the National Spinal Cord Injury Statistical Center, there are about 270,000 people in the U.S. with spinal cord injuries. Compared to the number of people suffering from more common conditions like diabetes or heart disease, says Jacono, “we are a decimal point in potential market size.”

They may not be hugely profitable, but the devices allow people to move again. Using an implantable pulse generator and series of electrodes, the devices create a parallel nervous system. Electrical stimulation runs through the wires to muscles and organs, thus returning function to the hands, bowels and bladder, restoring trunk control, cough reflex, relieving pressure sores, or even helping people stand again. The team is rolling out a plan to integrate multiple devices and wire them across a network.

Thus far, they’ve yet to run across a patient for whom the devices don’t restore some function. Peckham describes what he’s seen with the upper extremity device: turn it on, and they regain hand function. Turn it off again, they’re paralyzed.

“In the world of spinal cord injury there’s exactly the kind of technology that people have had access to for decades—wheel chairs, assistive technology. Then there’s the hope of a cure, through stem cells or some kind of natural, neurological regeneration. There’s no timetable to that,” says Jacono. “What we can deliver is a true reversal of spinal cord injury, for select functions, and we can do that in the near term.”

The devices offer dramatic results, but one company already failed in selling an earlier version of the upper extremity neuroprosthesis. Around 250 people received the device before the company collapsed. “It was backed by venture money and the growth of the company was not adequate to sustain the business. The product was enormously successful,” says Peckham, who was also lead researcher on the team that developed the device. “It was the financial model of that vehicle that was wrong. It wasn’t the technology.”

Seeing that company’s demise, and knowing that without some support the technology would never reach those who would benefit from it, Peckham and Jacono founded IFR to serve as a nonprofit proxy for the work that would normally be done under the auspices of a corporate body. “We have to find a way that’s going to make these breakthroughs available to people when there isn’t a standard commercial model,” says Peckham.

That last stage of medical translational research— taking drugs and treatments through the FDA’s final hurdle, a large pivotal study—isn’t cheap. This final step is normally bankrolled by a company hoping to legitimize a lucrative discovery. But there’s little incentive for companies to make an investment in proving efficacy without the promise of larger profits down the line. This reality has left the nonprofit IFR, operating with university and foundation support, in the unusual position of funding the translational research itself.

Peckham believes he’s under a moral obligation to see the research through to the end. “We have to find a way that’s going to make these breakthroughs available to people when there isn’t a standard commercial model,” he says.

Articles
Julian Meehan

Young leaders from around the world are gathering at the United Nations Headquarters in New York Saturday to address arguably the most urgent issue of our time. The Youth Climate Summit comes on the heels of an international strike spearheaded by Greta Thunberg, the 16-year-old climate activist from Sweden, who arrived in New York via emissions-free sailboat earlier this month.

Translated from Swedish, "berg" means "mountain," so it may feel fated that a young woman with Viking blood in her veins and summit in her name would be at the helm. But let's go out on a limb and presume Thunberg, in keeping with most activists, would chafe at the notion of pre-ordained "destiny," and rightly so. Destiny is passive — it happens to you. It's also egomaniacal. Change, on the other hand, is active; you have to fight. And it is humble. "We need to get angry and understand what is at stake," Thunberg declared. "And then we need to transform that anger into action."

This new generation of activists' most pernicious enemy is denial. The people in charge — complacent politicians and corporation heads who grossly benefit from maintaining the status quo — are buffered from real-life consequences of climate change. But millions of people don't share that privilege. For them, climate change isn't an abstract concept, but a daily state of emergency, whether it comes in the form of "prolonged drought in sub-Saharan Africa…devastating tropical storms sweeping across Southeast Asia, the Caribbean and the Pacific…[or] heatwaves and wildfires," as Amnesty International reportsare all too real problems people are facing on a regular basis.

RELATED: Greta Thunberg urges people to turn to nature to combat climate change

Keep Reading Show less
The Planet

Millions of people in over 150 countries across the globe marched for lawmakers and corporations to take action to help stop climate change on Friday, September 20.

The Climate Strikes were organized by children around the world as an extension of the of the "Fridays for Future" campaign. Students have been walking out of classrooms on Fridays to speak out about political inaction surrounding the climate crisis.

"We need to act right now to stop burning fossil fuels and ensure a rapid energy revolution with equity, reparations and climate justice at its heart," organizers say.

There's no doubt the visual images from the marches send a powerful message to those on the ground but especially those watching from around the world. GOOD's own Gabriel Reilich was on the scene for the largest of the Climate Strikes. Here are 18 of the best signs from the Climate Strike march in New York City.

Keep Reading Show less

September 20th marks the beginning of a pivotal push for the future of our planet. The Global Climate Strike will set the stage for the United Nations Climate Action Summit, where more than 60 nations are expected to build upon their commitment to 2015's Paris Agreement for combating climate change.

Millions of people are expected to take part in an estimated 4,000 events across 130 countries.

Keep Reading Show less
The Planet
via Apple

When the iPhone 11 debuted on September 10, it was met with less enthusiasm than the usual iPhone release. A lot of techies are holding off purchasing the latest gadget until Apple releases a phone with 5G technology.

Major US phone carriers have yet to build out the infrastructure necessary to provide a consistent 5G experience, so Apple didn't feel it necessary to integrate the technology into its latest iPhone.

A dramatic new feature on the iPhone 11 Pro is its three camera lenses. The three lenses give users the the original wide, plus ultrawide and telephoto options.

Keep Reading Show less
Health
via I love butter / Flickr

We often dismiss our dreams as nonsensical dispatches from the mind while we're deep asleep. But recent research proves that our dreams can definitely affect our waking lives.

People often dream about their significant others and studies show it actually affects how we behave towads them the next day.

"A lot of people don't pay attention to their dreams and are unaware of the impact they have on their state of mind," said Dylan Selterman, psychology lecturer at the University of Maryland, says according to The Huffington Post. "Now we have evidence that there is this association."

Keep Reading Show less
Health